News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gilead Sciences, Inc. (GILD)'s Hepatitis C Drug Works Better: FDA Reviewers



10/23/2013 7:45:17 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Gilead Sciences Inc's drug sofosbuvir is safe and effective when used in combination with other therapies to treat hepatitis C, according to reviewers with the U.S. Food and Drug Administration. Their review was posted on the FDA website on Wednesday ahead of a meeting on Oct. 25 of an outside panel of medical experts who will recommend whether or not the agency should approve the drug.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at ABC News
Read at Bloomberg


comments powered by Disqus
Reuters
ABC News
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES